NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 714663 | Null | 0.0208632511155816 | 0.47739431 |
NSC 715229 | Null | 0.0208632511155816 | 0.3028919 |
NSC 715973 | Null | 0.0208632511155816 | 0.30414445 |
NSC 736116 | 6-(3-Amonopropyl)-5,6-dihydro-9-methyl-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline Hydrochloride | 0.0208632511155816 | 0.37608704 |
NSC 744331 | (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd | 0.0208632511155816 | 0.42429127 |
NSC 756169 | GSK317314A | 0.0208632511155816 | 0.31920871 |
NSC 758664 | Sirolimus [USAN] | 0.0208632511155816 | -0.1076981 |
NSC 89822 | Null | 0.0208632511155816 | 0.40062576 |
NSC 142475 | Null | 0.0208632511155817 | 0.33912758 |
NSC 1433 | 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE | 0.0208632511155817 | 0.30934968 |